Comments
Loading...
Hemagen Diagnostics Analyst Ratings and Price Targets | OTC:HMGN | Benzinga
Hemagen Diagnostics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Hemagen Diagnostics Corp from these most-recent analyst ratings.
Analyst Ratings for Hemagen Diagnostics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Hemagen Diagnostics (HMGN) stock?
There is no price target for Hemagen Diagnostics
What is the most recent analyst rating for Hemagen Diagnostics (HMGN)?
There is no analyst for Hemagen Diagnostics
When was the last upgrade for Hemagen Diagnostics (HMGN)?
There is no last upgrade for Hemagen Diagnostics
When was the last downgrade for Hemagen Diagnostics (HMGN)?
There is no last downgrade for Hemagen Diagnostics.
When is the next analyst rating going to be posted or updated for Hemagen Diagnostics (HMGN)?
There is no next analyst rating for Hemagen Diagnostics.
Is the Analyst Rating Hemagen Diagnostics (HMGN) correct?
There is no next analyst rating for Hemagen Diagnostics.
Browse analyst ratings and price targets on all stocks.
